Picture of LAVA Therapeutics NV logo

LVTX — LAVA Therapeutics NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: LAVA Therapeutics Q2 basic EPS USD -0.48

Aug 22 (Reuters) - LAVA Therapeutics Q2 net income USD -12.7 million.
* Q2 pretax profit USD -12.603 million
* Q2 basic EPS USD -0.48
* Q2 gross profit USD 2.751 million
* Q2 operating expenses USD -16.296 million
* Q2 operating income USD -13.545 million

Recent news on LAVA Therapeutics NV

See all news